BioPlus Acquisition Corporation News - BIOS | Aktien NASDAQ

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (“BIOS” or the “Company”) (Nasdaq: BIOS) announced today that (i...

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now...

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors

Recently served as Boston Scientific Executive Vice President and Global Chief Medical Officer Professor...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ...

Current Report Filing (8-k)

false 0001856653 0001856653 2023-06-14 2023-06-14 0001856653 us-gaap:CapitalUnitsMember 2023-06-14 2023-06-14 0001856653...

Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando

EATONTOWN, N.J. and ORLANDO, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by BioPlus Acquisition Corp. pursuant to Rule 425 under the Securities Act of 1933 and...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by BioPlus Acquisition Corp. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to...

Quarterly Report (10-q)

falseQ10001856653--12-31NY 0001856653 2023-01-01 2023-03-31 0001856653 2022-01-01 2022-03-31 0001856653 2023-03-31 0001856653 2022-12-31...

Securities Registration: Business Combination (s-4)

Table of Contents false0001856653 0001856653 2022-01-01 2022-12-31 0001856653 2021-02-11 2021-12-31...

Proxy Statement (definitive) (def 14a)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

false 0001856653 0001856653 2023-05-02 2023-05-02 0001856653 bios:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneHalfOfOneRedeemableWarrantMemb...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

BioPlus Acquisition Corporation (BIOS)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

BIOS Nachrichten

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Quarterly Report (10-q)

Securities Registration: Business Combination (s-4)

Proxy Statement (definitive) (def 14a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

BIOS Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

BioPlus Acquisition Corporation (BIOS) News

BioPlus Acquisition Corporation (BIOS)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

BIOS Nachrichten

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate

Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Quarterly Report (10-q)

Securities Registration: Business Combination (s-4)

Proxy Statement (definitive) (def 14a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

BIOS Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen